Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs and Islet Co-transplantation in Chronic Pancreatitis Patients Undergoing TP-IAT
NCT05095532Phase 1Active, not recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2021
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised trial of bone marrow-derived mesenchymal stem cells in chronic pancreatitis (CP) (3 arms), sponsored by Medical University of South Carolina. Primary endpoint: Change in Islet Cell Function at 1 year. Started Dec 2021; status: active, not recruiting.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT05095532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095532.